share_log

SI-BONE (NASDAQ:SIBN Shareholders Incur Further Losses as Stock Declines 8.8% This Week, Taking Three-year Losses to 33%

SI-BONE (NASDAQ:SIBN Shareholders Incur Further Losses as Stock Declines 8.8% This Week, Taking Three-year Losses to 33%

si-bone(納斯達克股票代碼:SIBN)股東本週遭遇進一步損失,股價下跌8.8%,使得三年來的損失達到33%。
Simply Wall St ·  09/07 20:54

SI-BONE, Inc. (NASDAQ:SIBN) shareholders should be happy to see the share price up 14% in the last quarter. But that doesn't change the fact that the returns over the last three years have been less than pleasing. Truth be told the share price declined 33% in three years and that return, Dear Reader, falls short of what you could have got from passive investing with an index fund.

SI-BONE, Inc. (納斯達克:SIBN)股東應該對上季度股價上漲14%感到高興。但這並不能改變過去三年的回報令人不太滿意的事實。老實說,股價在三年內下跌了33%,這個回報,親愛的讀者,低於你通過指數基金進行被動投資可以獲得的收益。

If the past week is anything to go by, investor sentiment for SI-BONE isn't positive, so let's see if there's a mismatch between fundamentals and the share price.

如果過去一週有任何跡象,SI-BONE的投資者情緒並不樂觀,所以讓我們看看基本面和股價之間是否存在不匹配。

Because SI-BONE made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally hope to see good revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

由於SI-BONE在過去十二個月裏出現了虧損,我們認爲市場可能更加關注營業收入和營業收入增長,至少目前是這樣。當一家公司沒有盈利時,我們通常希望看到良好的營業收入增長。可以想象,快速的營業收入增長,如果能夠保持,往往會導致快速的利潤增長。

Over three years, SI-BONE grew revenue at 21% per year. That is faster than most pre-profit companies. The share price drop of 10% per year over three years would be considered disappointing by many, so you might argue the company is getting little credit for its impressive revenue growth. It's possible that the prior share price assumed unrealistically high future growth. Still, with high hopes now tempered, now might prove to be an opportunity to buy.

在三年內,SI-BONE的營收增長率爲每年21%。這比大多數未盈利的公司要快。在三年內,每年的股價下跌10%,對許多人來說可能令人失望,所以你可以說公司並沒有因其令人印象深刻的營業收入增長而得到足夠的認可。可能之前的股價假設了不切實際的高未來增長。儘管如此,現在希望很高,現在或許是一個購買的機會。

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

以下圖像顯示了公司的營業收入和盈利(隨時間變化)(單擊以查看準確的數字)。

big
NasdaqGM:SIBN Earnings and Revenue Growth September 7th 2024
納斯達克:SIBN的盈利和營收增長2024年9月7日

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

資產負債表強度至關重要。查看我們關於其財務狀況如何隨時間變化的免費報告可能很值得一看。

A Different Perspective

不同的觀點

SI-BONE shareholders are down 27% for the year, but the market itself is up 21%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 4% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 3 warning signs for SI-BONE that you should be aware of.

SI-BONE股東今年虧損27%,但市場上漲了21%。然而,請記住,即使是最好的股票有時也會在十二個月的時間內表現不佳。遺憾的是,去年的表現又是一個不好的結果,股東面臨了五年來每年總計損失4%。總的來說,長期股價的疲軟可能是一個不好的信號,儘管逆勢投資者可能希望研究該股票,希望能夠扭轉局面。我發現長期觀察股價作爲業務績效的一個代理非常有趣。但要真正獲得洞察力,我們還需要考慮其他信息。例如,我們已經發現了SI-BONE的3個風險信號,您應該了解。

Of course SI-BONE may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,SI-BONE可能不是最好的股票買入選擇。所以你可能希望看一下這個免費的增長股票集合。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論